Aleksandra Niedzwiecki en voeding

logo.jpg (7231 bytes)


Deze pagina is verouderd - ontvang onze nieuwtjes per email


Aleksandra Niedzwiecki

Aleksandra Niedzwiecki is werkzaam in het team van onderzoekers dat samenwerkt met Dr Rath en heeft baanbrekend onderzoek op haar naam staan. Ik kon geen informatie in Nederland vinden over haar werk dus helaas alleen Engelse info.


Aleksandra Niedzwiecki, Ph.D.

Executive Vice President and Director of Research, Dr. Niedzwiecki has been instrumental in the development and growth of Cellular Medicine research. Dr. Niedzwiecki is a leading biomedical researcher in the development of nutritional therapies for the treatment of diseases. She has a doctorate degree in biochemistry from the University of Warsaw, Poland. Dr. Niedzwiecki has held research faculty positions at Rockefeller University in New York, the University of Toronto, and the University of Warsaw.

She is the former director of cardiovascular research at the prestigious Linus Pauling Institute, formerly located in California. Dr. Niedzwiecki has conducted groundbreaking research in the molecular biology of aging, cellular metabolism, and cardiovascular disease. She has directly worked with the Nobel Laureates Linus Pauling and G.M. Edelman. Dr. Niedzwiecki has been an invited speaker at numerous conferences and scientific meetings, and she has published over 70 scientific publications in respected professional journals, written chapters in books, and authored several popular research articles. For the last 13 years, Dr. Niedzwiecki has been a close associate of Dr. Rath in conducting Cellular Medicine research. She is a Fellow of the American College of Nutrition and a member of the American Heart Association, the American Medical Women’s Association and other professional organizations.

More Compelling than NIH Study: Vitamin C's Effectiveness Against Cancer Stronger if Used in Synergy with Other Nutrients

The Dr. Rath Research Institute applauded the findings of Dr. Mark Levine and colleagues at the U.S. National Institutes of Health, which show that vitamin C has the potential to fight cancer when used in high dosages. The study confirms earlier research findings published in numerous scientific cancer journals by scientists from the Dr. Rath Research Institute.

The institute's research documents that vitamin C, when used in combination with the amino acids L-lysine and L-proline and a polyphenol fraction of green tea known as Epigallocatechin Gallate (EGCG), could not only kill cancer cells, but limit tumor growth, its infiltration by blood vessels (angiogenesis), and completely stop the invasion and spread of more than two dozen cancer cell types. While the NIH study showed a 50 percent decrease in survival of cancer cells exposed to high doses of vitamin C in five out of nine cancer cell types, the combination of nutrients used by Rath's group was effective not only in eliminating cancer cells, but in arresting cancer cell tissue invasion -- a hallmark of metastasis responsible for 90 percent of deaths from cancer. Today, there are no effective measures to stop cancer metastasis.

Dr. Matthias Rath, founder of the Dr. Rath Research Institute, said, "The use of lysine, an amino acid, in combination with ascorbic vitamin C addresses common pathomechanisms of cancer, will lead to a breakthrough in the control of many forms of cancer and other diseases." Dr. Rath first published his concept of the natural control of cancer in the Journal of Applied Nutrition in 1992.

Research that confirmed Dr. Rath's approach was publicized in an advertisement in USA Today on March 8, 2002. Further research was presented at the 19th Annual Miami Breast Cancer Conference in February of 2002; at the American Association of Cancer Research Special Conference in Cancer Research in South Carolina in October of 2002; at many other national and international conferences; and in many publications. The most recent findings can be found at the Breast Cancer Research Web site at

"By using nutrient synergy and defining correct biological targets, we could achieve superior physiological effects, which is not possible with a single nutrient therapy, even if applied at extreme doses," said Dr. Aleksandra Niedzwiecki, director of research at the institute.

The Dr. Rath Research Institute is calling for a radical change in the treatment of cancer, one that takes advantage of new natural approaches. Conventional approaches, such as chemotherapy and radiation, have been unsuccessful in reducing the high mortality rate of the disease, have contributed only to the accelerated cost of health care, and led to the development of new diseases that result from the side effects of these treatments.

The Dr. Rath Research Institute offers innovative, safe, effective, and natural solutions to cancer. To learn more, visit

Source: Dr. Rath Education Services USA, BV

Tumors in rats by combination of lysine, proline,
arginine, ascorbic acid and green tea extract

M Waheed Roomi, Nusrath W Roomi, Vadim Ivanov, Tatiana Kalinovsky, Aleksandra Niedzwiecki, M. Rath

The results of the present study showed that the specificnutrient mixture of lysine, proline, arginine, ascorbic acid,and green tea extract tested significantly inhibited the inci-dence, as well as the growth, of MNU-induced mammarytumors. Although clinical trials are necessary to assess theantitumor ability of the tested nutrient mixture on cancerpatients, the results of this study suggest strong potentialfor its use as a therapeutic regimen for inhibiting breastcancer development

Full report

New Research Indicates Essential Nutrients Can Inhibit the Spread of Deadly Pancreatic Cancer

Innovative research conducted by scientists under the direction of Aleksandra Niedzwiecki, Ph.D. at the Dr. Rath Research Institute indicates that the spread of pancreatic cancer can be inhibited with a specific nutrient combination. The research findings, published in the latest issue of the International Journal of Gastrointestinal Cancer (2005, Volume 35:2; 97-102), further validate Dr. Matthias Rath's novel approach to controlling cancer metastasis with essential nutrients.

There is no cure for pancreatic cancer, which has the poorest prognosis among cancer malignancies. Conventional approaches, including surgery, chemotherapy and radiation, have been unsuccessful reducing the high mortality rate of this disease. Dr. Rath's research team incubated the human pancreatic cell line MIA PaCa-2 with a nutrient mixture composed of vitamin C, lysine, other amino acids and green tea to observe its effects in inhibiting the proliferation and invasion of this deadly form of cancer.

This research direction was inspired by Dr. Rath's work who, in 1992, postulated that vitamin C and lysine could act as natural inhibitors of the degradation of connective tissue, a common pathomechanism in all types of malignancies. The study results corroborated earlier research with different types of cancer and showed that the nutrient mixture exerted a significant anti-proliferative effect and completely inhibited the invasion of pancreatic cancer cells. These nutrients also reduced the secretion of matrix metalloproteinases (MMPs), the enzymes that cancer cells use to degrade the surrounding connective tissue and spread in the body.

"Our research proves that specific nutrients can control pancreatic and other forms of cancer because they target the four characteristics of the disease -- proliferation, invasion, new blood vessel formation and cell survival," Dr. Niedzwiecki said. "This new data calls for a critical revision of current approaches to cancer and a focus on the development of natural, safe and effective means of controlling this devastating illness."

The Dr. Rath Research Institute has been leading the way in this new approach to cancer research based on the Cellular Medicine concept, which has consistently proven the powerful therapeutic effect of synergistically acting nutrients in controlling cancer development and spread. Research Institute scientists have presented the results of their work at numerous scientific conferences and published them in peer-reviewed scientific journals.

The Dr. Rath Research Institute offers innovative, safe and effective natural solutions to cancer. To learn more, visit




View My Stats